ArticleNature communications2026
Longitudinal dynamics of the maternal gut virome associate with metabolic features of preterm birth.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Funding
Abstract
Preterm birth (PTB) remains a major pregnancy complication, yet the role of the maternal gut virome in its etiology is largely unknown. Here we show that the maternal gut virome undergoes ecological destabilization prior to PTB, coupled with distinct host metabolic remodeling. Nested within the Tongji-Huaxi-Shuangliu Birth Cohort, we integrate longitudinal gut virome and bacteriome profiles from 300 stool samples, alongside matched serum metabolomes and clinical profiles, from 100 pregnant women (50 with PTB and 50 with term birth) across early, middle, and late pregnancy. We reveal that although the maternal gut virome is highly personalized and longitudinally stable within individuals, PTB is characterized by reduced virome convergence and specific alterations in viral populations emerging during mid-to-late pregnancy. Host-phage analyses identify remodeling of Klebsiella- and Prevotella-associated viral communities linked to PTB risk. PTB-associated virome alterations are further associated with amino acid metabolic remodeling, particularly glutamate- and aspartate-related pathways, supported by reproducible virus-metabolite associations and enriched viral auxiliary metabolic genes. In addition, L-aspartate partly mediates associations between monocyte-related inflammatory indices and PTB. Multi-omics modeling demonstrates that virome-metabolome signatures achieve strong predictive performance for both PTB and imminent delivery, with viral features contributing substantially to prediction accuracy and retaining predictive value in external validation. Collectively, these findings highlight the maternal virome and its metabolic signatures as key determinants of PTB susceptibility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.